MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

Search

Perrigo Co PLC

Uždarymo kaina

SektoriusSveikatos priežiūra

27.65 -1.46

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

27.37

Max

28.08

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-24M

-45M

Pardavimai

51M

1.1B

P/E

Sektoriaus vid.

2,570

73.239

Pelnas, tenkantis vienai akcijai

0.93

Dividendų pajamingumas

4.18

Pelno marža

-3.909

Darbuotojai

8,379

EBITDA

35M

114M

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+18.87% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

4.18%

3.06%

Kitas uždarbis

2025-05-06

Kitas dividendų mokėjimo data

2025-06-17

Kita Ex Dividend data

2025-05-29

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

415M

3.8B

Ankstesnė atidarymo kaina

29.11

Ankstesnė uždarymo kaina

27.65

Naujienos nuotaikos

By Acuity

24%

76%

55 / 386 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bullish Evidence

Perrigo Co PLC Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-02-28 17:42; UTC

Pagrindinės rinkos jėgos

Perrigo Shares Jump on FDA's Move to Reclassify Wisconsin Infant-Formula Plant

2025-02-27 23:52; UTC

Uždarbis

Perrigo Gets Facility Reclassification From FDA as 4Q Profit, Revenue Fall

Akcijų palyginimas

Kainos pokytis

Perrigo Co PLC Prognozė

Kainos tikslas

By TipRanks

18.87% į viršų

12 mėnesių prognozė

Vidutinis 33.33 USD  18.87%

Aukščiausias 42 USD

Žemiausias 27 USD

Remiantis 4 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Perrigo Co PLC kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

4 ratings

1

Pirkti

3

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

27.81 / 28.055Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Weak Bullish Evidence

Vidutinės trukmės periodas

Bullish Evidence

Ilgalaikis periodas

Strong Bullish Evidence

Rinkos nuotaikos

By Acuity

55 / 386 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Labai stiprus bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Perrigo Co PLC

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.